| Ticker | NGM |
|---|---|
| ISIN | US62921N1054 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trials for the treatment of non-alcoholic steatohepatitis (NASH); and MK-3655, an agonistic antibody that activates fibroblast growth factor receptor 1c-be...
El precio actual de NGM Biopharmaceuticals, Inc. (NGM) es de 1,54 , con una variación del -1,28%.
NGM Biopharmaceuticals, Inc. opera en el sector Healthcare, industria Biotechnology.
Compara brokers con acceso a las principales bolsas internacionales, con bajas comisiones, custodia y herramientas de análisis para invertir en acciones.
Compara brokers para acciones